Monthly IgG in seronegative women in endemic areas
Immediate treatment initiation on seroconversion
Patient Discharge Instructions
copy discharge instructions
Congenital toxoplasmosis home care
Medications: give all medications exactly as prescribed
Pyrimethamine: give every day (or as scheduled) without missing doses
Sulfadiazine: give twice daily with meals and plenty of water
Leucovorin (folinic acid): give with every pyrimethamine dose
Do not stop medications without speaking to your doctor
Lab monitoring: weekly blood tests are required
Weekly CBC while on daily pyrimethamine
Monthly CBC when switched to three-times-weekly schedule
Attend all scheduled blood draw appointments
Eye exams: keep all scheduled ophthalmology appointments
Eye exams every 3 months during the first year
Then at least once a year for life
New eye problems can appear throughout childhood and adulthood
Hearing tests: scheduled audiology evaluations
Hearing loss can develop late
Attend all scheduled audiology appointments
Developmental follow-up: keep all neurodevelopment appointments
Developmental delays can be caught early and helped with therapy
Warning signs to return to ER immediately
Head size growing rapidly or fontanelle (soft spot) bulging outward
May indicate hydrocephalus worsening
New seizure activity or return of seizures
Pallor, unusual bruising, petechiae (small red or purple spots on skin)
May indicate bone marrow suppression from medication
High fever, sore throat, or signs of infection
May indicate neutropenia from pyrimethamine
Eye turning inward or outward (new strabismus) or white reflex in eye
Poor feeding, vomiting, or unusual sleepiness or irritability
Development going backward (losing milestones previously achieved)
Medication safety reminders
Store pyrimethamine and sulfadiazine at room temperature away from children
If a dose is missed, contact your doctor or pharmacist for instructions
Ensure child drinks adequate fluids to prevent kidney stones from sulfadiazine
No over-the-counter medications without checking with your doctor (folate interaction risk)
When to call your doctor (non-urgent)
Rash or skin changes
Stomach upset or poor feeding lasting more than 1-2 days
Any concerns about growth or development
References
Guidelines and key sources
Primary guidelines
Office of AIDS Research Advisory Council (2025): Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV
Comprehensive neonatal and pediatric dosing protocols
Available at clinicalinfo.hiv.gov
ACOG Practice Bulletin No. 151: Cytomegalovirus, Parvovirus B19, Varicella Zoster, and Toxoplasmosis in Pregnancy (Obstetrics and Gynecology 2015)
Maternal screening and treatment guidance
IDSA/ASM Guide to Utilization of the Microbiology Laboratory 2024 (Clinical Infectious Diseases 2024)
Diagnostic testing recommendations including PCR methods
Landmark clinical studies
McLeod R et al. Outcome of Treatment for Congenital Toxoplasmosis 1981-2004: National Collaborative Chicago-Based Congenital Toxoplasmosis Study (Clinical Infectious Diseases 2006)
Defined benefit of 12-month treatment regimen
Demonstrated normal outcomes achievable with treatment
Guerina NG et al. Neonatal Serologic Screening and Early Treatment for Congenital Toxoplasma gondii Infection (NEJM 1994)
Established framework for neonatal screening and early treatment
Ribeiro SK et al. Treatment Protocols for Gestational and Congenital Toxoplasmosis Systematic Review (Microorganisms 2025)
RR 0.34 for infection and RR 0.30 for clinical manifestations with treatment
Recent reviews
Cerisola A et al. Congenital Toxoplasmosis (Seminars in Pediatric Neurology 2025)
Current clinical presentation and management overview
Nguyen TG et al. Diagnosis and Treatment of Congenital Toxoplasmosis: An Updated Overview (Expert Review of Anti-Infective Therapy 2026)
Updated diagnostic and therapeutic guidance
Journé A et al. Long-Term Ocular Outcomes in Congenital Toxoplasmosis Treated Perinatally (Pediatrics 2024)
Ophthalmic outcome data with treatment
Caceres A et al. Toxoplasma Gondii Infections in Pediatric Neurosurgery (Childs Nervous System 2024)
Neurosurgical management of hydrocephalus
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.